Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Galantamine for Metabolic Syndrome in Spinal Cord Injury
NCT07625332Phase 3Recruiting
- Sponsor
- Northwell Health
- Start
- Oct 2026
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
A Phase 3 trial of galantamine in metabolic syndrome, sponsored by Northwell Health. Started Oct 2026; status: recruiting.
02
Drugs
galantamine
03
Conditions
metabolic syndrome
Beyond the preview
Go deeper on NCT07625332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07625332.